← Research library

Bemitil for prevention of occupational hearing loss — patent RU2017483C1

Patent disclosure · 1994

What the patent describes
148 workers aged 22–24 exposed to intense aircraft-engine noise: placebo n=25, conventional prophylaxis n=39, Bemitil n=84.
Reported evidence
The patent reports hearing loss at one year in 8/25 placebo recipients, 7/39 receiving a standard multi-agent regimen, and 5/84 receiving Bemitil. Filed 9 November 1989; published 15 August 1994.

Reported patent results

Reported findings

The patent reports less hearing loss after one year in the Bemitil group.

148 workers aged 22–24 exposed to intense aircraft-engine noise: placebo n=25, conventional prophylaxis n=39, Bemitil n=84.

Population or model 148 workers aged 22–24 exposed to intense aircraft-engine noise: placebo n=25, conventional prophylaxis n=39, Bemitil n=84.

Results · Description: individual aircraft-technician example and 148-worker comparison.
MeasureResultComparison, timing and statistics
Hearing loss at one year5/84 with Bemitil, 7/39 with conventional prophylaxis, 8/25 with placeboHearing loss of varying degree; allocation and masking unverified · 1 year
Illustrative worker: recovery time4.5 hours without Bemitil versus 2 hours after a treatment cycleSingle-worker before/after example, not a cohort mean
Illustrative worker: high-frequency threshold shift45–55 dB without versus 30 dB after a Bemitil cycleAn individual example; exposure comparability not established

Unequal, apparently nonrandom groups and incomplete baseline/exposure data prevent a causal prevention estimate. Hearing protection remains a separate requirement.

Source for these results ↗ · Reviewed 2026-11-06

Patent claims and provenance

Use. Historical Bemitil-related hearing-protection use disclosure; patent reports are not independent randomized clinical evidence.

A patent disclosure is not clinical proof, marketing approval or a legal opinion. Related publications and patent family members may describe the same experiments.

Publication
RU2017483C1 ↗ · 1994-08-15
Earliest priority / filing
1989-11-09 / 1989-11-09
Original applicant / assignee
Глазников Лев Александрович
Indexed status
Not shown; official status unverified · checked 2026-11-06
Patent family
21478461 · family publications are related filings, not independent studies.
Original title, inventors and related publications

Agent for prophylaxis of professional hypoacusis

Inventors: Ю.К. Ревской; Л.А. Глазников; Б.Л. Макеев; В.Р. Гофман; М.А. Нестеров.

RU2017483C1

Original patent PDF ↗

Patent collection and status interpretation →

Study limitations and source details

Study limitations

  • Random allocation, blinding, exposure comparability and attrition are not established by the patent.
  • Patent claims are not equivalent to a peer-reviewed clinical trial or confirmed prevention.
  • This does not replace hearing protection or occupational exposure controls.

Source details

Patent text and dates checked. The numerical comparison is attributed to the patent, not independently verified patient data.

Selected reported results and source limitations reviewed; not a complete risk-of-bias or experimental audit.

Sources checked

Citation

Patent / reported experimentsFull text available

L. A. Glaznikov, Iu. K. Revskoi, B. L. Makeev, V. R. Gofman, M. A. Nesterov. Bemitil for prevention of occupational hearing loss — patent RU2017483C1 Russian patent RU2017483C1; priority 1989

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards